Epidemiology of Breast Cancer

• Breast cancer is the most common type of cancer diagnosed in women:
  • Comprising 30% of all women’s cancer diagnoses in the United States:
    • The American Cancer Society estimates that:
      • 268,600 new cases of breast cancer will be diagnosed in women in 2019:
        • Along with about 2670 cases in men:

          • In addition 48,100 cases of DCIS will be diagnosed among women

      • After lung cancer:
        • Breast cancer is the second leading cause of cancer-related death in women:
          • Accounting for 15% of cancer-related deaths:
            • Approximately 41,760 women and 500 men:
              • Are expected to die from breast cancer in 2019

• The incidence of breast cancer has consistently outpaced the incidence of all other cancers (excluding indolent cutaneous malignancies) in women in the US:
  • As of 2015:
    • The incidence rate of female breast cancer in the US was:
      • 124.8 per 100,000 population
  • Of note, the incidence of invasive breast cancers decreased between 1999 and 2004:
    • Which coincides with and is possibly attributable to:
      • Better adherence to recommended screening mammography for the general population of women
      • As well as decreasing use of menopausal hormone replacement therapy (HRT)

• Worldwide:
  • Breast cancer is the leading cause of cancer death in women

• Although the United States and Western Europe have a five-fold higher number of new cases of breast cancer compared with Africa and Asia:
  • Since 1990:
    • The death rate of breast cancer has declined by 24% in the United States (as well as other countries in Western Europe):
      • This may be due to:
        • Increased use of screening mammography
        • Much better adjuvant chemotherapy therapy

 

• Given the high incidence and mortality of breast cancer:
  • Defining the risk factors for breast cancer has significant clinical value:
    • Physicians can use this information to work with patients to minimize modifiable factors, and to determine appropriate screening procedures

 

• Rodrigo Arrangoiz MS, MD, FACS cirujano oncology y cirujano de mamá de Sociedad Quirúrgica S.C en el America British Cowdray Medical Center en la ciudad de Mexico:
  • Es experto en el manejo del cáncer de mama.

👉Es miembro de la American Society of Breast Surgeons:

Training:

• General surgery:

• Michigan State University:

• 2004 al 2010

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• Fox Chase Cancer Center (Filadelfia):

• 2010 al 2012

• Masters in Science (Clinical research for health professionals):

• Drexel University (Filadelfia):

• 2010 al 2012

• Surgical Oncology / Head and Neck Surgery / Endocrine Surgery:

• IFHNOS / Memorial Sloan Kettering Cancer Center:

• 2014 al 2016

#Arrangoiz

#Surgeon

#Cirujano

#SurgicalOncologist

#CirujanoOncologo

#BreastSurgeon

#CirujanodeMama

#CancerSurgeon

#CirujanodeCancer